Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mucositis × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1

Conditions

Breast Neoplasms 64 Neoplasms 60 Prostatic Neoplasms 45 Colorectal Neoplasms 37 Lung Neoplasms 34 Carcinoma, Non-Small-Cell Lung 24 Hematologic Neoplasms 20 Neoplasm Metastasis 18 Head and Neck Neoplasms 18 Pancreatic Neoplasms 16 Multiple Myeloma 15 Urinary Bladder Neoplasms 14 Ovarian Neoplasms 12 Motor Activity 11 Leukemia, Myeloid, Acute 11 Stomach Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Melanoma 8 Hematopoietic and Lymphatic System Neoplasm 8 Glioblastoma 8 Gastrointestinal Neoplasms 8 Anxiety Disorders 8 Triple Negative Breast Neoplasms 7 Glioma 7 Esophageal Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Renal Cell 7 COVID-19 7 Uterine Cervical Neoplasms 6 Sarcoma 6

Interventions

Radiotherapy 7 Cisplatin 6 Radiation 4 Injections 4 Fibroblast Growth Factor 7 4 angiotensin I (1-7) 3 Propolis 3 Morphine 3 Low-Level Light Therapy 3 Drug Therapy 3 aluminum hydroxide, magnesium hydroxide, drug combination 2 Xylitol 2 Water 2 Radiotherapy, Intensity-Modulated 2 RRx-001 2 Probiotics 2 Pentoxifylline 2 Mouthwashes 2 Methotrexate 2 Melphalan 2 Lidocaine 2 Leucovorin 2 Interleukin 1 Receptor Antagonist Protein 2 Honey 2 Gabapentin 2 Fluorouracil 2 Diphenhydramine 2 Cryotherapy 2 Amifostine 2 tempol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01917942 2017-07-12

RadioHum

Trans Tasman Radiation Oncology Group

Phase 3 Completed

Head & NeckOther

Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡